{"id":151035,"date":"2020-08-22T22:23:12","date_gmt":"2020-08-22T22:23:12","guid":{"rendered":"https:\/\/www.bnreport.com\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/"},"modified":"2020-08-22T22:23:12","modified_gmt":"2020-08-22T22:23:12","slug":"small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai","status":"publish","type":"post","link":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/","title":{"rendered":"Small Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI"},"content":{"rendered":"

Since March AstraZeneca (LON:AZN) has inked three significant deals with some lesser lights of the drugs sector quoted on the LSEs alternative investment market.<\/p>\n

Remember, the Anglo-Swedish giant, which is now the FTSE 100s largest company, has one of the industrys most productive drugs pipelines and is noted for some innovative industry collaborations.<\/p>\n

Its interest in AIM started with an out-licensing agreement with Silence Therapeutics (LON:SLN) worth up to \u00a3303mln per disease area in commercial development milestones and tiered royalty payments.<\/p>\n

This came coupled with an upfront payment and equity investment of \u00a361mln that means the gene silencing specialist wont have to worry about its bank balance for many years.<\/p>\n

RedX Pharma was the next to feel the AZ love with a transaction like Silences, but worth slightly less at \u00a3283mln (plus a \u00a313mln down-payment).<\/p>\n

RedX shares are up more than 400% in the year to date at 38p, while Silence has enjoyed a rather more modest 27% uplift in that time to 456p.<\/p>\n

Friday saw the drug giant deepen its association with AIM after striking a collaboration with artificial intelligence-driven diagnostics specialist, RenalytixAI (LON:RENX), whose stock shot up 14% to 645p.<\/p>\n

The pair will work on precision medicine strategies for cardiovascular, renal and metabolic diseases.<\/p>\n

AZ also has longer-standing ties with Hutchison China MediTech (LON:HCM), one of AIMs largest companies, and Circassia Group (LON:CIR), the asthma management specialist, where it is the largest investor.<\/p>\n

Turning to the wider market, the AIM All-Share was more or less flat this week at 956 points, which meant it outperformed significantly the top stocks benchmark, with the FTSE 100 down almost 1.5% in that period.<\/p>\n

Sticking with the AIM winners, it was another stellar week for 7Digital (LON:7DIG), which rocketed 180% higher to 3.21p.<\/p>\n

So hot has the stock been recently that a \u00a31,000 investment a month ago would be worth \u00a313,600. The springboard for this weeks movement was a music deal with an unnamed tech giant.<\/p>\n

Before looking at the weeks losers, worth an honourable mention is HC Slingsby (LON:SLNG), up 79% to 220p after reporting bumper demand for its industrial equipment.<\/p>\n

But down 24.5% at 13.9p this week was Europa Metals (LON:EUZ), though this was purely technical after the company raised \u00a32mln of new cash to do something positive \u2013 to fund the completion of key components of a pre-feasibility study for its Toral lead-zinc-silver project in Spain.<\/p>\n

Europas was one of a number of fundraisers on AIM over the week that included share placings by Active Energy (LON:AEG), Equatorial Palm Oil (LON:PAL), Immedia (LON:IME), Eurasia Mining (LON:EUA) and One Media IP (LON:OMIP).<\/p>\n

Digital rights specialist One Medias \u00a36mln funder stood out as it was heavily over-subscribed, suggesting there is still plenty ofRead More \u2013 Source<\/a>
\n[contf]
\n[contfnew]
\n <\/p>\n

Proactiveinvestors<\/a><\/h5>\n

[contfnewc]
\n[contfnewc]<\/p>\n","protected":false},"excerpt":{"rendered":"

Since March AstraZeneca (LON:AZN) has inked three significant deals with some lesser lights of the d..<\/p>\n","protected":false},"author":1,"featured_media":151036,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46],"tags":[],"class_list":["post-151035","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-politics"],"yoast_head":"\nSmall Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI - Business News Report<\/title>\n<meta name=\"description\" content=\"Since March AstraZeneca (LON:AZN) has inked three significant deals with some lesser lights of the d..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Small Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI - Business News Report\" \/>\n<meta property=\"og:description\" content=\"Since March AstraZeneca (LON:AZN) has inked three significant deals with some lesser lights of the d..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/\" \/>\n<meta property=\"og:site_name\" content=\"Business News Report\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-22T22:23:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/08\/1200z630_1598007496_drugs-astrazeneca.jpe\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"infopal11\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BNReport\" \/>\n<meta name=\"twitter:site\" content=\"@BNReport\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"infopal11\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\\\/\"},\"author\":{\"name\":\"infopal11\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\"},\"headline\":\"Small Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI\",\"datePublished\":\"2020-08-22T22:23:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\\\/\"},\"wordCount\":474,\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/1200z630_1598007496_drugs-astrazeneca.jpe\",\"articleSection\":[\"Politics\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\\\/\",\"name\":\"Small Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI - Business News Report\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/1200z630_1598007496_drugs-astrazeneca.jpe\",\"datePublished\":\"2020-08-22T22:23:12+00:00\",\"description\":\"Since March AstraZeneca (LON:AZN) has inked three significant deals with some lesser lights of the d..\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/1200z630_1598007496_drugs-astrazeneca.jpe\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/1200z630_1598007496_drugs-astrazeneca.jpe\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Small Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"name\":\"Business News Report\",\"description\":\"Latest News on the World of Politics & Business\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\",\"name\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"width\":200,\"height\":50,\"caption\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Business-NewsReport-328225811095934\\\/\",\"https:\\\/\\\/x.com\\\/BNReport\",\"https:\\\/\\\/www.instagram.com\\\/business.newsreport\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\",\"name\":\"infopal11\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/author\\\/infopal11\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Small Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI - Business News Report","description":"Since March AstraZeneca (LON:AZN) has inked three significant deals with some lesser lights of the d..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/","og_locale":"en_US","og_type":"article","og_title":"Small Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI - Business News Report","og_description":"Since March AstraZeneca (LON:AZN) has inked three significant deals with some lesser lights of the d..","og_url":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/","og_site_name":"Business News Report","article_publisher":"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","article_published_time":"2020-08-22T22:23:12+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/08\/1200z630_1598007496_drugs-astrazeneca.jpe","type":"image\/jpeg"}],"author":"infopal11","twitter_card":"summary_large_image","twitter_creator":"@BNReport","twitter_site":"@BNReport","twitter_misc":{"Written by":"infopal11","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/#article","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/"},"author":{"name":"infopal11","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f"},"headline":"Small Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI","datePublished":"2020-08-22T22:23:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/"},"wordCount":474,"publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/08\/1200z630_1598007496_drugs-astrazeneca.jpe","articleSection":["Politics"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/","url":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/","name":"Small Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI - Business News Report","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/#primaryimage"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/08\/1200z630_1598007496_drugs-astrazeneca.jpe","datePublished":"2020-08-22T22:23:12+00:00","description":"Since March AstraZeneca (LON:AZN) has inked three significant deals with some lesser lights of the d..","breadcrumb":{"@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/#primaryimage","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/08\/1200z630_1598007496_drugs-astrazeneca.jpe","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/08\/1200z630_1598007496_drugs-astrazeneca.jpe","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.bnreport.com\/en\/small-cap-movers-drugs-giant-inks-collaboration-deal-with-artificial-intelligence-driven-diagnostics-specialist-renalytixai\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/www.bnreport.com\/en\/"},{"@type":"ListItem","position":2,"name":"Small Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI"}]},{"@type":"WebSite","@id":"https:\/\/www.bnreport.com\/en\/#website","url":"https:\/\/www.bnreport.com\/en\/","name":"Business News Report","description":"Latest News on the World of Politics & Business","publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bnreport.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.bnreport.com\/en\/#organization","name":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a","url":"https:\/\/www.bnreport.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","width":200,"height":50,"caption":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","https:\/\/x.com\/BNReport","https:\/\/www.instagram.com\/business.newsreport"]},{"@type":"Person","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f","name":"infopal11","url":"https:\/\/www.bnreport.com\/en\/author\/infopal11\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/151035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/comments?post=151035"}],"version-history":[{"count":0,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/151035\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media\/151036"}],"wp:attachment":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media?parent=151035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/categories?post=151035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/tags?post=151035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}